Trials / Conditions / Stage IV Lung Cancer

Stage IV Lung Cancer

27 registered clinical trials studyying Stage IV Lung Cancer — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Pilot Randomized Clinical Trial of Informational Support Versus Spiritual Care NCT07176559	Indiana University	N/A
Terminated	Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors NCT06654245	Wake Forest University Health Sciences	N/A
Active Not Recruiting	Shortened High-dose Palliative Radiotherapy for Lung Cancer NCT06483308	University Hospitals Coventry and Warwickshire NHS Trust	N/A
Active Not Recruiting	A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources NCT06383988	Wake Forest University Health Sciences	N/A
Withdrawn	Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs NCT04985357	Travera Inc	—
Withdrawn	An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer NCT06427369	Roswell Park Cancer Institute	Phase 1
Recruiting	Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients NCT06538038	PrECOG, LLC.	—
Recruiting	Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation NCT06110572	Vanderbilt-Ingram Cancer Center	Phase 1 / Phase 2
Recruiting	Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung NCT06896890	Inhatarget Therapeutics	Phase 1 / Phase 2
Terminated	Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skippin NCT05435846	Collin Blakely	Phase 1
Completed	Ask Questions (ASQ):Implementation of a Communication Intervention NCT05025748	Barbara Ann Karmanos Cancer Institute	N/A
Terminated	Brigatinib and Binimetinib in Treating Patients With Stage IIIB-IV ALK or ROS1-Rearranged Non-small Cell Lung NCT04005144	University of California, San Francisco	Phase 1
Unknown	Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites NCT04267575	Jerome Canady, M.D.	N/A
Completed	Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer NCT03867175	Wake Forest University Health Sciences	Phase 3
Completed	Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partn NCT03112668	Rutgers, The State University of New Jersey	N/A
Completed	Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients NCT03222258	Seoul National University Hospital	—
Completed	Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of Life NCT02606149	Assistance Publique - Hôpitaux de Paris	N/A
Completed	CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Meta NCT02693080	Stanford University	Phase 1
Completed	Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, NCT02318771	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1
Terminated	A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advan NCT02109016	Clovis Oncology, Inc.	Phase 2
Completed	Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR NCT01556191	Intergroupe Francophone de Cancerologie Thoracique	Phase 2
Terminated	A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer NCT02128373	Case Comprehensive Cancer Center	N/A
Terminated	IPI-504 in NSCLC Patients With ALK Translocations NCT01228435	Massachusetts General Hospital	Phase 2
Completed	Lung Cancer Informational Study (LCIS) NCT00579215	Memorial Sloan Kettering Cancer Center	N/A
Terminated	Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer NCT00003492	Burzynski Research Institute	Phase 2
Terminated	Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer NCT00003495	Burzynski Research Institute	Phase 2
Terminated	Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer NCT00003491	Burzynski Research Institute	Phase 2